Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joanna Hindley

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
Trials|May 8, 2026
Tools to help patients and other stakeholders' input into choice of intercurrent event strategy for estimands in randomised trialsJoanna Hindley, Charlotte Hartley, Jennifer Hellier, et al.
Molecular Oncology|September 16, 2021
Circulating tumour DNA is a promising biomarker for risk stratification of central chondrosarcoma with IDH1/2 and GNAS mutationsIben Lyskjaer, Christopher Davies, Anna-Christina Strobl, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
Trials|May 8, 2026
Tools to help patients and other stakeholders' input into choice of intercurrent event strategy for estimands in randomised trialsJoanna Hindley, Charlotte Hartley, Jennifer Hellier, et al.
Molecular Oncology|September 16, 2021
Circulating tumour DNA is a promising biomarker for risk stratification of central chondrosarcoma with IDH1/2 and GNAS mutationsIben Lyskjaer, Christopher Davies, Anna-Christina Strobl, et al.
Pageof 1